Cardiovascular Business February 12, 2025
One of the world’s largest healthcare technology companies is considering a sale of its stroke business, according to a new report from Financial Times. The asking price is believed to be more than $1 billion.
According to multiple anonymous sources familiar with the matter, Johnson & Johnson has had early discussions with potential buyers about its Cerenovus line of stroke products. Johnson & Johnson first launched Cerenovus in 2017 after it combined its acquisitions of Pulsar Vascular and Neuravi.
In September 2024, the company announced that...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices